NEW YORK (GenomeWeb News) - Genedata said today it has extended a contract with Nycomed for its Genedata Screener software in pharmaceutical development projects.
Screener will enable Nycomed’s researchers to “rapidly capture, visualize, analyze, and manage large volumes of assay data,” Genedata said in a statement.
Nycomed’s head of high-throughput screening, Werner Stürmer, said Screener will increase efficiency and quality of screening campaigns and will have a positive impact on the company’s global information network.
The software will help Nycomed’s teams at all of its sites “capture, visualize, analyze, and manage large volumes of assay data,” coming from ultra-high throughput screens, single point assays, and high content screens.
In November, the companies announced that Genedata would develop and implement scientific databases and other applications for Nycomed’s research-data management and scientific analysis.